In a recent decision, the Calcutta High Court upheld an appeal filed by BTS Research International Pty Ltd (“BTS”) challenging the rejection by the Assistant...
Read more about Hybrid Cell Inventions: Section 3(j) of the Patents Act Does Not ApplyTag: Patent Eligibility
Madras High Court Affirms Rejection of AI-Integrated Persona Patent
The Madras High Court dismissed an appeal challenging the rejection of a patent application for AI-integrated persona augmentation. The Court ruled that the invention lacked sufficient technical detail, inventive step, and patent-eligible subject matter under the Patents Act. It upheld the Controller’s decision, emphasizing the absence of tangible technical effects and clear disclosure requirements.
Read more about Madras High Court Affirms Rejection of AI-Integrated Persona PatentMethods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion
The Madras High Court ruled that methods for producing antibodies in genetically modified animals are patentable under Indian law and are not excluded by Section 3(i). This decision clarifies the scope of patent eligibility for biotechnological inventions involving animal models.
Read more about Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) ExclusionMonoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)
The Madras High Court clarified the interpretation of Section 3c regarding patent eligibility of monoclonal antibodies in India. The Court held that synthetic antibodies may be patentable if they demonstrate novelty or technical advancement.
Read more about Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)Engineered non-living substances are not excluded under Section 3(c) of the Patents Act, 1970.
The Madras High Court held that Section 3c of the Patents Act, 1970 does not exclude engineered non-living substances from patent protection. The ruling clarifies the distinction between discovery and invention for biotechnology patents in India.
Read more about Engineered non-living substances are not excluded under Section 3(c) of the Patents Act, 1970.Patent Agent Exam 2022 Announced
The Patent Agent Exam 2022, organised by the Office of CGPDTM, is scheduled for May 2022. Applications are open to eligible science and engineering graduates, with accommodations available for persons with disabilities.
Read more about Patent Agent Exam 2022 AnnouncedPatent Filing Essentials
This post summarises the key requirements for filing a patent in India, including eligibility, timing, and procedural steps. It highlights essential documents and legal considerations for inventors seeking patent protection.
Read more about Patent Filing EssentialsPatentability of Laws of Nature
This post analyses the Mayo v Prometheus case and its impact on the patentability of laws of nature in the US. It explains the judicial reasoning that established the requirement of an innovative step beyond the mere application of natural laws for patent eligibility.
Read more about Patentability of Laws of NatureAlice vs. CLS saga
The Alice vs. CLS case significantly influenced the landscape of software patent protection in the US, particularly for financial technologies. It raised critical questions about the patentability of abstract ideas and has shifted industry standards and legal strategies.
Read more about Alice vs. CLS sagaThe Gene Returns to its Body
Judge Sweet’s landmark ruling held that isolated gene sequences and their analysis are not patentable under US law. This decision invalidated key BRCA gene patents and marks a significant shift in the legal approach to biotechnology patents in the United States.
Read more about The Gene Returns to its Body